Comment
. 2002 May;59(5):466-7; author reply 467-8.
doi: 10.1001/archpsyc.59.5.466.
Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
- PMID: 11982452
- DOI: 10.1001/archpsyc.59.5.466
Item in Clipboard
Comment
Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
Arch Gen Psychiatry.
2002 May.
No abstract available
Comment in
-
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.Arch Gen Psychiatry. 2002 Jul;59(7):663-4. doi: 10.1001/archpsyc.59.7.663. Arch Gen Psychiatry. 2002. PMID: 12090822 No abstract available.
Comment on
-
Glutamate receptor dysfunction and schizophrenia.Arch Gen Psychiatry. 1995 Dec;52(12):998-1007. doi: 10.1001/archpsyc.1995.03950240016004. Arch Gen Psychiatry. 1995. PMID: 7492260
-
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.Arch Gen Psychiatry. 2000 Mar;57(3):270-6. doi: 10.1001/archpsyc.57.3.270. Arch Gen Psychiatry. 2000. PMID: 10711913 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
